祛风化瘀通络方早期干预急性缺血性脑卒中42例

江云东; 江玉; 王明杰; 潘洪

doi:10.11653/syfj2013230282

您当前的位置：

首页 >

文章列表页 >

祛风化瘀通络方早期干预急性缺血性脑卒中42例

更新时间：2024-01-04

- 祛风化瘀通络方早期干预急性缺血性脑卒中42例
- Early Intervention of Qufeng Huayu Tongluo Formulae on 42 Cases Acute Ischemic Stroke Patients
- 中国实验方剂学杂志 2013年19卷第23期页码：282-285
- 作者机构：
- 作者简介：
- 基金信息：
  
  四川省教育厅项目(川教函[2011]538号11ZB130);泸州市科技局项目(泸市科[2012]177)
- DOI：10.11653/syfj2013230282
  中图分类号：
- 纸质出版日期：2013
- 稿件说明：
移动端阅览
江云东, 江玉, 王明杰, 等. 祛风化瘀通络方早期干预急性缺血性脑卒中42例[J]. 中国实验方剂学杂志, 2013,19(23):282-285.

JIANG Yun-dong, JIANG Yu, WANG Ming-jie, et al. Early Intervention of Qufeng Huayu Tongluo Formulae on 42 Cases Acute Ischemic Stroke Patients[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(23): 282-285.
江云东, 江玉, 王明杰, 等. 祛风化瘀通络方早期干预急性缺血性脑卒中42例[J]. 中国实验方剂学杂志, 2013,19(23):282-285. DOI： 10.11653/syfj2013230282.

JIANG Yun-dong, JIANG Yu, WANG Ming-jie, et al. Early Intervention of Qufeng Huayu Tongluo Formulae on 42 Cases Acute Ischemic Stroke Patients[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(23): 282-285. DOI： 10.11653/syfj2013230282.

摘要

目的: 观察祛风化瘀通络方早期干预急性缺血性脑卒中（CIS）的临床疗效及作用机制。方法: 85例CIS患者随机按数字法分为对照组43例和观察组42例。两组均参照“中国急性缺血性脑卒中诊治指南2010”给予西医常规治疗。观察组在对照组治疗的基础上加用祛风化瘀通络方，1剂/d，疗程2周。以美国国立卫生研究院卒中量表（NIHSS）评估神经功能缺损严重程度，以Fugl-Meyer运动功能评价量表（FMI）评估肢体运动功能，以改良Ashworth痉挛评定量表评价肢体痉挛程度;记录中医证候评分;检测血清血管假性血友病因子（vWF）、血栓素B2（TXB2）、6-酮-前列环素Flα（6-Keto-PGFlα）、同型半胱氨酸（HCY）水平及血小板功能。结果: 治疗后第7、14天观察组NIHSS评分和改良Ashworth评分均低于对照组，FMI评分高于对照组（P<0.01）;治疗后第7、14天观察组中医证候评分下降幅度多于对照组（P<0.01）;治疗后观察组vWF，TXB2及HCY水平均低于对照组，6-Keto-PGF1α高于对照组（P<0.01）;治疗后观察组平均血小板体积及血小板聚集率均低于对照组（P<0.01）。结论: 祛风化瘀通络方早期干预急性缺血性脑卒中，能改善患者中医临床症状及神经功能缺损症状，其作用机制可能与抑制血小板激活，抗血小板活化，改善血管缩舒功能有关。

Abstract

Objective: The purpose is to observe the clinical curative effect and mode of action of Qufeng Huayu Tongluo Formulae in the early intervention of acute ischemic stroke (CIS). Method: Eiety-five cases of CIS patients were randomly divided into control group (43 cases) and observation group (42 cases) according to digital method. According to 'China Diagnosis and Treatment of Acute Ischemic Stroke Guidelines 2010'

patients in both group were given conventional western medicine treatment. Based on the treatment of observation group

patients in the control group took Qufeng Huayu Tongluo Formulae

1 dose/day

treatment course 2 weeks. Nerve function defect severity was assessed by the United States National Institutes of Health Stroke Scale (NIHSS). Limb movement function was assessed by Fugl-Meyer motor function assessment scale (FMI). Limb spasm degree was assessed by modified Ashworth spasm rating scale. Traditional Chinese medicine syndrome scores were recorded.Levels of serum vascular pseudo willebrand factor (vWF)

thromboxane B2 (TXB2)

6-ketone-Prostcyclin F1a (6-Keto-PG F1a) and homocysteine (HCY) levels and platelet function were detected. Result: On the 7th day and 14th day after treatment

the NIHSS score and modified Ashworth score of observation group were lower than the control group

while FMI score higher than the control group (P<0.01). The falling range of traditional Chinese medicine syndrome scores of observation group was larger than the control group (P<0.01).After treatment

the levels of vWF

TXB2 and HCY of observation group were lower than the control group

while 6-Ketone-PG F1a was higher than the control group (P <0.01). The mean platelet volume and platelet aggregation rate of observation group were lower than control group (P<0.01). Conclusion: In the early intervention of acute ischemic stroke

Qufeng Huayu Tongluo Formulae can improve patient's clinical symptoms of Traditional Chinese Medicine and neural function defect symptom. Its mechanism may be related to inhibit platelet activation and platelet activation

improve the function of vasoconstriction.

关键词

Keywords

references

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

通窍活血汤联合针刺治疗卒中后认知障碍疗效及对患者神经递质、神经功能的影响

柴胡、赤芍与醋柴胡、杭白芍对大鼠高脂血症作用的实验研究

补阳还五汤配合依达拉奉治疗急性缺血性脑卒中48例

中风防治灵丸对脑缺血大鼠神经功能及脑水肿的影响

不同中药序贯疗法对痰瘀互结证急性冠脉综合征血小板功能的影响